Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Brian Montague

Vascular & Interventional Radiology Tampa, FL Medical Doctor

NPI 1962504621 CMS profile 43137

4516 N Armenia Ave, Tampa, FL 33603

Open in the dashboard

General payments

$9,766

346 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Brian Montague of Tampa, FL is reported in the CMS Open Payments database as having received $9,766 across 346 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 77th percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,624 100
2024 General $2,775 81
2023 General $2,059 52
2022 General $883 32
2021 General $1,146 35
2020 General $563 21
2019 General $716 25

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Brian Montague
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Brian Montague were reported at $1,624. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Brian Montague Vascular & Interventional Radiology median Middle half National median
2019 $716 $422 $125–$1,555 $163
2020 $563 $200 $68–$652 $114
2021 $1,146 $280 $99–$866 $132
2022 $883 $433 $137–$1,497 $149
2023 $2,059 $506 $152–$2,019 $160
2024 $2,775 $556 $175–$1,930 $164
2025 $1,624 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Inari Medical, Inc. $2,962 30 payments
  2. Penumbra, Inc. $1,015 46 payments
  3. Sirtex Medical Inc $748 32 payments
  4. Medtronic, Inc. $652 30 payments
  5. Imperative Care, INc $601 48 payments
  6. Stryker Corporation $575 41 payments
  7. Cook Medical LLC $495 22 payments
  8. Bard Peripheral Vascular, Inc. $447 16 payments
  9. DePuy Synthes Sales Inc. $434 14 payments
  10. AngioDynamics, Inc. $322 11 payments
  11. Other $1,516 56 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $9,016 345 payments
  2. Consulting Fee $750 1 payment
Products named General payments · program years 2019–2025
  1. FLOWTRIEVER CATHETER, S $3,012 32 payments
  2. CT THROMBECTOMY SYSTEM KIT $2,660 28 payments
  3. SIR-Spheres Microspheres $569 22 payments
  4. Indigo System $567 30 payments
  5. KYPHON EXPRESS II KYPHOPAK TRAY $383 18 payments
  6. EMBOTRAP $297 12 payments
  7. FLOWTRIEVER $206 18 payments
  8. LAVA LES (Liquid Embolic System) $179 10 payments
  9. Indigo $161 1 payment
  10. RUBY Coil $155 7 payments
  11. Other $4,125 190 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 253 billing codes

Paid by Medicare

$108,004

Of which drugs: $1,390

Medicare patients

1,216

Average age 76

Services billed

7,508

725 women, 491 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 68%
Ischemic heart disease 54%
Chronic kidney disease 46%
Diabetes 44%
Depression 43%
Heart failure 38%
Atrial fibrillation 36%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, gadobutrol, 0.1 ml A9585 Office 49 3,747 $963
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Q9967 Office 17 1,745 $173

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

346 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular & Interventional Radiology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record